Pharmacological Modulation of Dopamine Receptor D2-Mediated Transmission Alters the Metabolic Phenotype of Diet Induced Obese and Diet Resistant C57Bl6 Mice
Figure 4
Glucose infusion rate during a hyperinsulinemic euglycemic clamp in DIO and DR mice after treatment with bromocriptine (BC), haloperidol (HP), or placebo (P) for 2 weeks. Data is presented as mean ± SD for 9 or 10 mice per group. *; ***.
